- AVF Academy
- Advancing Evidence in DVT Treatment: CLEANER Vac® and the CLEAR-VIEW XT Study
Advancing Evidence in DVT Treatment: CLEANER Vac® and the CLEAR-VIEW XT Study
Pete Stibbs, MD, MSc, MBASVP, Global Medical Affairs and Medical Director
Argon Medical Devices
For many patients with deep vein thrombosis (DVT), the immediate diagnosis is only the beginning of a much longer clinical pathway. Factors such as residual thrombus, impaired venous outflow, leg pain, swelling, reduced mobility, and post-thrombotic syndrome can continue to affect quality of life long-term, even after the acute event has been treated. Despite advances in anticoagulation and endovascular care, a clear need remains for data supporting treatment strategies that can rapidly restore flow, minimize treatment burden, and help physicians prevent long-term venous damage in their patients.
Argon Medical Devices is addressing that need through a clinical evidence program for the CLEANER Vac® Thrombectomy System. A retrospective 200-patient multicenter study was recently completed and provided important real-world data that mechanical thrombectomy with CLEANER Vac® can support efficient thrombus removal, frequently in a single treatment session, while limiting reliance on prolonged thrombolytic therapy. This study’s abstract will be formally presented at the CIRSE Annual Congress 2026.
Argon’s prospective CLEAR-VIEW XT study represents the next step in advancing that evidence. This study evaluates thrombus removal, safety, venous patency, symptom resolution, quality of life measures, post-thrombotic syndrome, hospital stay information, adjunctive therapy, and reintervention through 24 months of follow-up.
By prospectively evaluating these outcomes, CLEAR-VIEW XT is intended to provide a more comprehensive understanding of patient outcomes following treatment with CLEANER Vac®.
To learn more about CLEANER Vac®, visit: https://www.argonmedical.com/product/cleaner-vac-thrombectomy-system/ Caution: Federal (USA) law restricts these devices to sale by or on the order of a physician. Prior to use, please refer to the Instructions for Use for complete product indications, contraindications, warnings, and detailed instructions for use.
Investigators interested in learning more about participation opportunities in the CLEAR-VIEW XT study are encouraged to contact Argon Medical Devices or visit: https://clinicaltrials.gov/study/NCT07102160



